TOOsonix

TOOsonix is a private Danish medical device company developing and commercializing high-frequency, image-guided high-intensity focused ultrasound systems for dermatology and aesthetic skin treatment. Its lead product, System ONE-M, is an MDR CE-marked device marketed in Europe for a range of dermatologic and cosmetic indications, including basal cell carcinoma, actinic keratosis, common warts, acne-related lesions, and selected vascular and benign skin conditions. The company positions its technology as a non-invasive alternative or complement to surgery, cryotherapy, lasers, photodynamic therapy, and topical treatments, emphasizing precision, low pain, and minimal downtime. TOOsonix was founded in 2017 and is based in Hørsholm, Denmark, with backing from Consolidated Holdings and an expanding distributor network across Europe, the Middle East, and North Africa.